Senzime, a global leader in precision-based perioperative monitoring solutions, announced the formation of a new Medical Affairs division and the parallel launch of Senzime Academy—an open-access education platform designed to advance the implementation of guideline-supported neuromuscular monitoring worldwide.
“These initiatives aim to drive the next wave of clinical transformation in anesthesia care, as Senzime continues to strengthen our role not only as a device innovator, but as a scientific and educational partner,” said Philip Siberg, CEO of Senzime. “Our new Medical Affairs team and educational platform reflect our commitment to partnering with providers to implement evidence-based practices that elevate patient outcomes.”
Health Technology Insights: Centivo Strengthens Leadership Team with Appointment of Chief Financial Officer
Building a Global Clinical Community
Senzime’s new Medical Affairs division will serve as a hub for collaboration with leading academic centers, anesthesia providers, and perioperative teams. Its mission is to translate clinical research into real-world practice, support best-in-class implementation, and elevate global awareness about the ongoing risks of residual neuromuscular block (rNMB). The division is led by Jen Sanders, Director of Clinical and Medical Affairs.
Addressing the Real-World Needs of Anesthesia Teams
To support widespread adoption of neuromuscular monitoring, Senzime Academy offers clinicians on-demand training on quantitative train-of-four (TOF) monitoring and best practices for TetraGraph use. The digital platform includes video modules, clinical case examples, and implementation guides for both adult and pediatric care settings.
Health Technology Insights: Luminopia’s Amblyopia Treatment Approved for Coverage by Anthem
Built on 40+ Years of Scientific Research
Senzime’s flagship TetraGraph system is the result of over four decades of neuromuscular monitoring research, translated into a clinically robust, EMG-based platform purpose-built to meet the demands of modern surgery. Its proprietary TOF monitoring technology is clinically evaluated in 19 peer-reviewed publications, making it the most studied EMG system available today. TetraGraph is used in over 3,500 operating rooms worldwide, supporting compliance with best practices outlined by the American Society of Anesthesiologists and the European Society of Anaesthesiology and Intensive Care (ESAIC).
Health Technology Insights: Copper River Acquires Aspire Medical to Expand Healthcare Staffing
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
